Skip to main content

Table 1 Patients’ clinical characteristics

From: Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?

Characteristics

Value

(%)

Gender (No. of patients)

 Male

65

(65.0)

 Female

35

(35.0)

Age (years)

 Median

67

 

 Range

41–83

 

Tumor clinical stage (No. of patients)

  

 cT3

85

(85.0)

 cT4

15

(15.0)

Nodal clinical stage (No. of patients)

 cN0

32

(32.0)

 cN+

68

(68.0)

Rectal segment, distance to the anal verge

 Upper third

20

(20.0)

 Middle third

42

(42.0)

 Lower third

38

(38.0)

Pathological stage (No. of patients)

 ypT0 N0

16

(16.0)

 ypT1 N0-N1

5

(5.0)

 ypT2 N0-N2

19

(19.0)

 ypT3 N0-N1-N2

56

(56.0)

 ypT4 N0-N1-N2

4

(4.0)

TRG (No. of patients)

 TRG 1

16

(16.0)

 TRG 2

15

(15.0)

 TRG 3

25

(25.0)

 TRG 4

22

(22.0)

 TRG 5

22

(22.0)

  1. No number, TRG Tumor regression grade